Abstract:With the increase of global cancer morbidity and mortality, it is of great importance to control the development of cancer. In recent years, plenty of strategies have been developed for tumor diagnosis and therapy. As one of the major approaches, ligand-mediated receptor-introduced drug delivery has been extensively studied over the past decade. Our laboratory mainly engages in the related researches on the combined diagnosis and treatment of tumors, especially glioma. A series of smart biocompatible theranostic systems were designed and constructed, including precise oligomer-based nanoparticles, polymer-coated nitrogen carbon nanodots, multifunctional mesoporous silica graphite nanosheets, magnetic graphene mesoporous silica nanoparticles, etc. Then, based on the design of specific ligand-receptor targeting strategies such as IL-13, Angiopep and I6P7, these systems were applied for tumor-targeted drug delivery, gene therapy, photothermal therapy and tumor imaging. For example, the nuclear localization signal sequence LNP in Lim kinase 2 protein, was used to modify the dendrimer-based nano gene delivery system. With the ability to cross the blood-brain barrier, the translocation efficiency of nanoparticles and anti-glioma effect were improved. And, the new controlled drug delivery system, using graphene as nanocarrier, was prepared with excellent properties, such as pHand NIRresponsive, and controlled drug release, showing chemotherapeutic and photothermal synergistic therapy of glioma. A receptor-mediated cascade-targeting drug delivery system, which constructed by polymer-coated nitrogen-carbon nanodots and a multifunctional peptide (I6P7) with the ability to transport through the blood-brain barrier, target glioma and inhibit the expression of tumor growth factors, were constructed for the imaging-guided combined glioma therapy. Relating work provides new ideas and theoretical basis for cancer theragnosis.

Recent progress in functional peptides designed for tumor-targeted imaging and therapy

Peptide‐Based Multifunctional Nanomaterials for Tumor Imaging and Therapy

Recent Development on Peptide-Based Probes for Multifunctional Biomedical Imaging

Research progresses on the functional polypeptides in the detection and imaging of breast cancer

Research Progresses on the Functional Polypeptides in the Detection and Imaging of Breast Cancer.

Recent Progress in Peptide-Based Molecular Probes for Disease Bioimaging

Peptide‐Functionalized Inorganic Oxide Nanomaterials for Solid Cancer Imaging and Therapy

New Frontiers in Molecular Imaging Using Peptide-Based Radiopharmaceuticals for Prostate Cancer

Peptide-based targeted therapeutics and apoptosis imaging probes for cancer therapy

The multifaceted roles of peptides in “always-on” near-infrared fluorescent probes for tumor imaging

Programmable Assembly of Multivalent DNA‐Protein Superstructures for Tumor Imaging and Targeted Therapy

Recent Advances in Imaging Agents Anchored with pH (Low) Insertion Peptides for Cancer Theranostics

Construction of Targeting-Peptide-Based Imaging Reagents and Their Application in Bioimaging

Peptide-Based Nanomaterials for Tumor Immunotherapy

New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology

Peptide-based nanoprobes for molecular imaging and disease diagnostics

Progress on radionuclide-labeled small peptides in targeting tumor angiogenesis

Peptide-Mediated Tumor-Targeted Diagnosis and Therapy

Functional Materials for Subcellular Targeting Strategies in Cancer Therapy: Progress and Prospects

Functionalizing tetrahedral framework nucleic acids-based nanostructures for tumor in situ imaging and treatment

Polypeptides-Based Nanocarriers in Tumor Therapy